Genzyme Survives Virus Infection at Allston Manufacturing Plant and Resumes Drug Production

SUGAR LAND--October 1, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In a move befitting an industry laden with irony, a virus infection forced the Genzyme Corporation (NASDAQ:GENZ) to shut down the company's biopharmaceutical plant in Allston Landing, Massachusetts. The virus strain Vesivirus 2117, which was found in the site's six bioreactors, interferes with the growth of CHO cells, a component in biologic drug production.